Empirical Financial Services LLC d.b.a. Empirical Wealth Management Raises Stock Holdings in Pediatrix Medical Group, Inc. $MD

Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 8.7% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 11,913 shares of the company’s stock after buying an additional 950 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management’s holdings in Pediatrix Medical Group were worth $171,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the stock. SummerHaven Investment Management LLC boosted its stake in shares of Pediatrix Medical Group by 1.0% in the second quarter. SummerHaven Investment Management LLC now owns 113,480 shares of the company’s stock worth $1,628,000 after buying an additional 1,153 shares during the last quarter. State of Alaska Department of Revenue boosted its stake in shares of Pediatrix Medical Group by 7.0% in the second quarter. State of Alaska Department of Revenue now owns 50,096 shares of the company’s stock worth $717,000 after buying an additional 3,262 shares during the last quarter. Counterpoint Mutual Funds LLC purchased a new stake in shares of Pediatrix Medical Group in the second quarter worth about $755,000. Marshall & Sullivan Inc. WA purchased a new stake in shares of Pediatrix Medical Group in the second quarter worth about $41,000. Finally, Diversified Trust Co boosted its stake in shares of Pediatrix Medical Group by 30.4% in the second quarter. Diversified Trust Co now owns 21,255 shares of the company’s stock worth $305,000 after buying an additional 4,950 shares during the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Trading Up 0.0%

MD stock opened at $17.65 on Wednesday. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. Pediatrix Medical Group, Inc. has a 12-month low of $11.59 and a 12-month high of $18.22. The stock has a market cap of $1.54 billion, a price-to-earnings ratio of 13.68 and a beta of 1.26. The business’s 50-day moving average is $16.02 and its 200 day moving average is $14.46.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The company had revenue of $468.84 million for the quarter, compared to analysts’ expectations of $464.37 million. During the same period in the previous year, the firm posted $0.34 EPS. Pediatrix Medical Group’s revenue was down 7.1% compared to the same quarter last year. On average, sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Wall Street Analyst Weigh In

MD has been the topic of a number of recent research reports. UBS Group upped their target price on Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. Zacks Research upgraded Pediatrix Medical Group to a “strong-buy” rating in a research report on Monday, August 11th. Wall Street Zen upgraded Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Weiss Ratings restated a “hold (c)” rating on shares of Pediatrix Medical Group in a research report on Saturday, September 27th. Finally, Leerink Partners raised their target price on Pediatrix Medical Group from $14.50 to $17.00 and gave the company a “market perform” rating in a research report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Pediatrix Medical Group currently has a consensus rating of “Hold” and a consensus price target of $16.79.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.